Imagion Biosystems Ltd (IBX) — Cash Flow-to-Debt Ratio
Imagion Biosystems Ltd (IBX) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of AU$-2.27 Million could theoretically repay -1% of its total liabilities (AU$4.21 Million) in one year. Check IBX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Imagion Biosystems Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Imagion Biosystems Ltd across 12 annual periods. Also explore total assets of Imagion Biosystems Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Imagion Biosystems Ltd (2014–2025)
Year-by-year debt coverage analysis for Imagion Biosystems Ltd. For market capitalisation and broader financial context, see Imagion Biosystems Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.96x | AU$-4.04 Million | AU$4.21 Million | ▼ -284.9% |
| 2024 | -0.25x | AU$-1.27 Million | AU$5.09 Million | ▲ +74.8% |
| 2023 | -0.99x | AU$-8.32 Million | AU$8.37 Million | ▲ +34.8% |
| 2022 | -1.52x | AU$-8.07 Million | AU$5.30 Million | ▲ +75.6% |
| 2021 | -6.26x | AU$-5.07 Million | AU$809.88K | ▼ -63.1% |
| 2020 | -3.84x | AU$-4.62 Million | AU$1.21 Million | ▼ -74.2% |
| 2019 | -2.20x | AU$-4.18 Million | AU$1.90 Million | ▲ +64.3% |
| 2018 | -6.17x | AU$-8.13 Million | AU$1.32 Million | ▲ +39.1% |
| 2017 | -10.13x | AU$-6.98 Million | AU$688.77K | ▼ -1613.3% |
| 2016 | -0.59x | AU$-267.26K | AU$451.99K | ▼ -35.1% |
| 2015 | -0.44x | AU$-4.22 Million | AU$9.65 Million | ▲ +22.4% |
| 2014 | -0.56x | AU$-2.43 Million | AU$4.31 Million | — |